The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
NPHC · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | MDT | AKBA | NPHC | PROF |
|---|---|---|---|---|
| Moat Score (0–100) | 51 (highest) | 51 (highest) | 51 (highest) | 51 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 62 | 41 | 70 | 75 (highest) |
| Pricing power | 100 (highest) | 70 | 62 | 100 (highest) |
| Returns on capital | 6 (highest) | 0 | — | 0 |
| Balance-sheet safety | 35 | 100 (highest) | 28 | 55 |
| Capital allocation | 52 (highest) | 44 | 44 | 24 |
| 92% above value if growth stopped today | No price data | No price data | No price data | |
| Market cap | $120.6B | $186M | $709973 | $240M |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2026 | FY2025 | FY2025 | FY2025 |